AU2001291750A1 - Lat peptides and their use in assays for identifying immunosuppressants - Google Patents

Lat peptides and their use in assays for identifying immunosuppressants

Info

Publication number
AU2001291750A1
AU2001291750A1 AU2001291750A AU9175001A AU2001291750A1 AU 2001291750 A1 AU2001291750 A1 AU 2001291750A1 AU 2001291750 A AU2001291750 A AU 2001291750A AU 9175001 A AU9175001 A AU 9175001A AU 2001291750 A1 AU2001291750 A1 AU 2001291750A1
Authority
AU
Australia
Prior art keywords
lat
assays
peptides
immunosuppressants
identifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291750A
Other languages
English (en)
Inventor
Gerhard Zenke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma GmbH
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2001291750A1 publication Critical patent/AU2001291750A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001291750A 2000-08-09 2001-08-07 Lat peptides and their use in assays for identifying immunosuppressants Abandoned AU2001291750A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0019632.9A GB0019632D0 (en) 2000-08-09 2000-08-09 Organic compounds
GB0019632 2000-08-09
PCT/EP2001/009134 WO2002012275A2 (en) 2000-08-09 2001-08-07 Lat peptides and their use in assays for identifying immunosuppressants

Publications (1)

Publication Number Publication Date
AU2001291750A1 true AU2001291750A1 (en) 2002-02-18

Family

ID=9897335

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291750A Abandoned AU2001291750A1 (en) 2000-08-09 2001-08-07 Lat peptides and their use in assays for identifying immunosuppressants

Country Status (6)

Country Link
US (1) US20100168031A1 (ja)
EP (1) EP1309622A2 (ja)
JP (1) JP2004505991A (ja)
AU (1) AU2001291750A1 (ja)
GB (1) GB0019632D0 (ja)
WO (1) WO2002012275A2 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0206215D0 (en) 2002-03-15 2002-05-01 Novartis Ag Organic compounds
GB0321710D0 (en) 2003-09-16 2003-10-15 Novartis Ag Organic compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9722818D0 (en) * 1997-10-30 1997-12-24 Peptide Therapeutics Ltd A method for mapping the active sites bound by enzymes that covalently modify substrate molecules
CA2316769A1 (en) * 1997-12-23 1999-07-01 Lawrence E. Samelson The protein tyrosine kinase substrate lat and its use in the identification of (ant)agonists of the kinase

Also Published As

Publication number Publication date
EP1309622A2 (en) 2003-05-14
JP2004505991A (ja) 2004-02-26
WO2002012275A3 (en) 2002-04-11
GB0019632D0 (en) 2000-09-27
WO2002012275A2 (en) 2002-02-14
US20100168031A1 (en) 2010-07-01

Similar Documents

Publication Publication Date Title
AU2001288249A1 (en) Biosensors and methods for their use
AU2001270260A1 (en) 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
AU2002211717A1 (en) Stresscopins and their uses
AU2001264852A1 (en) Lactobacillusbeta -glucuronidase and dna encoding the same
GB0026134D0 (en) Peptides and their use
AU2001263257A1 (en) Online patent and license exchange
AU2001272655A1 (en) Improvements in valves
AU2001291750A1 (en) Lat peptides and their use in assays for identifying immunosuppressants
AU4432001A (en) Trityl-type compounds and their use
AU2001279090A1 (en) Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases
IL145711A0 (en) Thrombospondin-2 and uses thereof
AU2001261697A1 (en) Methods for identifying novel therapeutics and diagnostics in the p53 pathway
AU2001280993A1 (en) Tissue-associated proteins and their uses
GB0020952D0 (en) Genes and proteins and their uses
AU2002256556A1 (en) Sea-trosy and related methods
AU2001252621A1 (en) Novel proetin and use thereof
AU2002214307A1 (en) T cell line and use thereof
AU2001294267A1 (en) Survivin-like polypeptides and dnas thereof
AU2001231917A1 (en) Isolated complex comprising a nnt-1 protein and in addition at least a clf-1 protein and/or a scntfralpha protein
GB0030726D0 (en) Assay methods and kits therefor
AU2001256680A1 (en) Hiv-producing cell line and use thereof
AU2001256454A1 (en) Prion proteins and their uses
AU9446901A (en) Assay method and kit therefor
GB0002559D0 (en) Virulencegene and protein and their use
GB0019503D0 (en) Proteins and their uses